A Genetic Screen in Drosophila for Metastatic Behavior

Science

Volumn 302, Issue 5648, 2003, Pages 1227-1231

  Pagliarini, Raymond A ^a   Xu, Tian ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MEMBRANES; GENES; MUTAGENESIS; ONCOLOGY; TISSUE; TUMORS;

SECONDARY TUMOR FORMATION;

GENETIC ENGINEERING;

GREEN FLUORESCENT PROTEIN; RECOMBINASE; UVOMORULIN;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTENNA; ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CELL MIGRATION; CELL POLARITY; CONTROLLED STUDY; DROSOPHILA; EMBRYO; GENE MUTATION; GENE OVEREXPRESSION; GENETIC SCREENING; GENOME; IMAGINAL DISC; METASTASIS; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; BASEMENT MEMBRANE; CADHERINS; CELL DIVISION; CELL POLARITY; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; EPITHELIAL CELLS; EYE; GENE SILENCING; GENES, INSECT; GENES, RAS; GENES, TUMOR SUPPRESSOR; GENETIC SCREENING; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; MEMBRANE PROTEINS; MODELS, ANIMAL; MUTATION; NEOPLASM METASTASIS; NEOPLASMS; TRANSGENES;

ANIMALIA;

EID: 0242666126     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1088474     Document Type: Article

References (39)

1. A. F. Chambers, A. C. Groom, I. C. MacDonald, Nature Rev. Cancer 2, 563 (2002).
2. P. S. Steeg, Nature Rev. Cancer 3, 55 (2003).
3. C. J. Potter, G. S. Turenchalk, T. Xu, Trends Genet. 16, 33 (2000).
4. R. A. Pagliarini, A. T. Quinones, T. Xu, in Tumor Suppressor Genes: Regulation, Function, and Medicinal Applications, W. S. El-Deiry, Ed. (Humana, Totowa, NJ, 2003). pp. 349-381.
5. See supporting material on Science Online.
6. T. P. Newsome, B. Asling, B. J. Dickson, Development 127, 851 (2000).
7. ey also expresses in the CNS, ocelli, and Bolwig's organ. In larvae, however, eyFLP did not produce visible clones outside of the noted locations.
8. M. A. St. John et al., Nature Genet. 21, 182 (1999).
9. F. D. Karim, G. M. Rubin, Development 125, 1 (1998).
10. G. H. Fisher et al., Genes Dev. 15, 3249 (2001).
11. T. Xu, W. Wang, S. Zhang, R. A. Stewart, W. Yu, Development 121, 1053 (1995).
12. V12-expressing cells in mosaic flies were also made homozygous for additional second-site mutations (862 mutant lines): reduced tumor growth (76 lines), enhanced tumor growth (9 lines), and tumors with metastatic behavior (2 lines).
13. D. Bilder, N. Perrimon, Nature 403, 676 (2000).
14. D. Bilder, M. Li, N. Perrimon, Science 289, 113 (2000).
15. M. Egeblad, Z. Werb, Nature Rev. Cancer 2, 161 (2002).
16. X. Morin, R. Daneman, M. Zavortink, W. Chia, Proc. Natl. Acad. Sci. U.S.A. 98, 15050 (2001).
17. When using the GFP-labeled collagen IV protein trap, mutant cells were marked with UAS-lacZ instead of UAS-GFP.
18. A. K. Perl., P. Wilgenbus, U. Dahl, H. Semb, G. Christofori, Nature 392, 190 (1998).
19. T. Uemura et al., Genes Dev. 10, 659 (1996).
20. U. Tepass et al., Genes Dev. 10, 672 (1996).
21. J. L. Genova, S. Jong, J. T. Camp, R. G. Fehon, Dev. Biol. 221, 181 (2000).
22. H. A. Muller, E. Wieschaus, J. Cell Biol. 134, 149 (1996).
23. D. Bilder, M. Schober, N. Perrimon, Nature Cell Biol. 5, 53 (2003).
24. G. Tanentzapf, U. Tepass, Nature Cell Biol. 5, 46 (2003).
25. A. Bergmann, J. Agapite, K. McCall, H. Steller, Cell 95, 331 (1998).
26. D. A. Prober, B. A. Edgar, Cell 100, 435 (2000).
27. W. Du, J. E. Xie, N. Dyson, EMBO J. 15, 3684 (1996).
28. B. A. Hay, T. Wolff, G. M. Rubin, Development 120, 2121 (1994).
29. L. A. Johnston, D. A. Prober, B. A. Edgar, R. N. Eisenman, P. Gallant, Cell 98, 779 (1999).
30. J. Verdu, M. A. Buratovich, E. L. Wilder, M. J. Birnbaum, Nature Cell Biol. 1, 500 (1999).
31. J. P. Thiery, Nature Rev. Cancer 2, 442 (2002).
32. P. Guilford, Mol. Med. Today 5, 172 (1999).
33. R. Bernards, R. A. Weinberg, Nature 418, 823 (2002).
34. T. Xu, G. M. Rubin, Development 117, 1223 (1993).
35. T. Lee, L. Luo, Neuron 22, 451 (1999).
36. K. Ito, W. Awano, K. Suzuki, Y. Hiromi, D. Yamamoto, Development 124, 761 (1997).
37. A. H. Brand, N. Perrimon, Development 118, 401 (1993).
38. M. Therrien, A. M. Wong, G. M. Rubin, Cell 95, 343 (1998).
39. We thank D. DiMaio, A. Horwich, R. Lifton, D. Stem, and K. White for critical review; R. Li, T. Ni, and H. Lee for participating in the screen; X. Fei for transgene injections; E. Hersperger and A. Sheam for teaching transplantation techniques; and D. Bilder, M. Bimbaum, H. Chang, L. Cooley, R. Fehon, P. Gallant, I. Hariharan, B. Hay, X. Morin, H. Oda, J. P. Vincent, and T. Uemura for strains and reagents. Supported by NIH grant CA69408 (T.X.) and the Linda Tallen and David Paul Kane Educational and Research Foundation. T.X. is a HHMI Investigator, R.A.P. is a predoctoral fellow in the Department of Genetics.